|1||Active, not recruiting||
Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease
Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
† Study has passed its completion date and status has not been verified in more than two years.